Clinical Trial

Clinical Trial Search

Click here to learn more about participating in Clinical Trials.

Trial Protocol ID STRO-002-GM3 RIT

Trial Description

***REFERRAL ONLY*** REFRaME-O1: A Phase 2/3 Open-label Study Evaluating the Efficacy and Safety of Luveltamab Tazevibulin (STRO-002) versus Investigator’s Choice (IC) Chemotherapy in Women with Relapsed Platinum-resistant Epithelial Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing Folate Receptor Alpha (FOLR1)

Disease Types

Ovarian

Sponsor

Sutro BioPharma

Clinical Trial

Clinical Trial Search

Trial Protocol ID STRO-002-GM3 *RIT*

Disease Types

Sponsor

Trial Protocol ID STRO-002-GM3 RIT